Keep up to date with the latest news from Accelagen

Tag

Showing 0 of 100

Insights & Expertise

Why working with a local Australian sponsor can help fast-track your market authorisation

Meet the Study Start-Up Team at Accelagen: Unique roles, one purpose

Staff announcement

Meet Chris Goon: Head of Medical Affairs at Accelagen

Staff announcement

Meet Madeleine Reynard: The Organisational Force Behind Accelagen

Staff announcement

Delivering a Data-Driven Future at Accelagen: Meet Janus and Jessie

Staff announcement

Why Regulatory Affairs is the Backbone of Accelagen’s Expertise: Introducing Our Newest Regulatory Affairs Officers

Staff announcement

Welcoming Ano Chinogurei as Accelagen’s People & Culture Lead

Insights & Expertise

How Accelagen’s Medical Team is elevating clinical trial excellence

Staff announcement

Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher

Staff announcement

The people powering progress: Meet Accelagen’s latest CRA recruits

Accelerating Equity: Women in Biotech and Creating an Inclusive Workplace Culture

Staff announcement

Putting people first: Dr. Eleanor Guest joins Accelagen’s Executive Leadership Team

Staff announcement

Welcoming our new Business Planning and Analysis Manager

Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results

Staff announcement

Accelagen Staff Announcement: Amritha Vangur

Accelagen Staff Announcement: Suzanne Leong

Accelagen Staff Announcement: Sian Gilmour

Rapid growth puts Australian CRO Accelagen on the map

Insights & Expertise

Best in class standards at scale

Insights & Expertise

How Accelagen is Navigating Regulatory Lifecycle Management

Join Accelagen and Griffith University for a Webinar Highlighting a Groundbreaking Clinical Trial for Spinal Cord Injury using Cell-Based Therapy in Australia

Insights & Expertise

Tailored Clinical Trial Data Management with Accelagen

Insights & Expertise

Navigating regulatory complexity with forward thinking innovation at Accelagen

Meet with Accelagen at BIO International 2025 in Boston, MA to Discuss the Australian Advantage!

Insights & Expertise

Finding Certainty in Uncertain Times: Why Accelagen is the Reliable CRO Alternative Amid U.S. Regulatory Turmoil

Fifteen Years of Accelagen: What’s next? Global Expansion and Our Commitment to Improving Human Health

Fifteen Years of Accelagen: Our Journey to Building a Future in Clinical Research

Insights & Expertise

Fifteen Years of Accelagen: Beyond the Status Quo - A Dynamic Approach to Clinical Research

Insights & Expertise

Clean Data, Clear Decisions: Accelagen’s Impact on Clinical Trial Success

Certainty in a Changing Market: Accelagen on the US Biotech Stage

Insights & Expertise

Certified Precision: The Accelagen Approach to Reliable Clinical Trial Data

Bringing the Australian Advantage to Europe: Accelagen and Partners Unite at Swiss Biotech Day 2025

Insights & Expertise

Accelerating Success: How Accelagen’s Strategic Site Feasibility Drives Better Operational Outcomes

Accelagen’s Trent Wadford to Attend the Chicago BioLife Summit: Guiding Biotechs Toward Smarter, Faster Clinical Development

Advantage Australia: Accelagen Showcases Australia’s Clinical Trial Edge on European Stage

Insights & Expertise

Accelagen’s boutique clinical project management is built for sponsors and patients alike

Accelagen to Attend OCT Europe 2025: Supporting Global Clinical Innovation with Australian Excellence

Insights & Expertise

Accelagen Offers a Full Suite of Regulatory Submission Management Services

Insights from JP Morgan and Accelagen's Outlook for the CRO Industry in 2025

Staff announcement

An Introduction to Mathew Palmer, Accelagen's Chief Growth & Commercial Officer

Accelagen Partners with Griffith University on Groundbreaking World-First Clinical Trial for Treating Spinal Cord Injuries

Accelagen attending JP Morgan Health Conference in San Francisco

Insights & Expertise

Biometric Support by Accelagen from a Data Management Perspective

Insights & Expertise

World-Class Medical Monitoring Offered Worldwide by Accelagen

Insights & Expertise

Accelagen Offers a Full Suite of Regulatory Submission Management Services

Insights & Expertise

Accelagen Offers Assurance and Convenience by Using Proven CDISC Standards with the Cutting-edge ePRO System

Accelagen Biggest Takeaway from Bio International in 2024: Interest in the Australian Advantage

Accelagen will be on-hand in San Diego next week for Bio 2024

Insights & Expertise

The Value of Strategic Consultation in Regulatory Affairs from Accelagen

Insights & Expertise

Streamline Your Clinical Trial Processes with Full-Service CRO Expertise

Insights & Expertise

The Advantage of Team Australia: Speed, Accuracy, and Reduced Cost

Accelagen Continues Strategic Expansion into the U.S. During JP Morgan 2024

No results found.

There are no results with this criteria. Try changing your search.